NuVasive

Global Orthopedic Implants Market 2023 - 2028: Featuring Conmed, Medtronic, Stryker and NuVasive Among Others

Retrieved on: 
Wednesday, January 25, 2023
Research report, The Surgery Center at Doral, COVID-19, Dental implant, Glass, Hospital, Ceramic, Polymer, US, Osteoarthritis, Biopolymer, Trauma, Prevalence, Arthritis, Baxter, 2052: A Global Forecast for the Next Forty Years, Medtronic, Stryker Corporation, NuVasive, Injury, Accident, Investment, Medical device, Dentistry, Growth

The Global Orthopedic Implants Market is anticipated to reach US$ 68.71 Billion by 2028 according to the publisher.

Key Points: 
  • The Global Orthopedic Implants Market is anticipated to reach US$ 68.71 Billion by 2028 according to the publisher.
  • Furthermore, technical advancements like robot-assisted surgical instruments, acceptance of implanted medical devices, and widespread use of orthopedic implants to treat musculoskeletal and orthopedic illnesses, & injuries are boosting the orthopedic implants market growth.
  • By Application: Joint Reconstruction holds the lion's share:
    Based on application, the orthopedic implants market is divided into joint reconstruction, spinal implants, trauma implants, dental implants, orthobiologics, and others.
  • The leading players are implementing strategies like product innovations, mergers, acquisitions, collaborations, partnerships, joint ventures, and new advancements to strengthen their global market position in the orthopedic implants market.

Insights on the Intraoperative Neuromonitoring (IONM) Global Market to 2027: Augmenting Focus on Patient Safety During Complex Surgical Procedures Drives Growth

Retrieved on: 
Monday, January 23, 2023
DSM-IV codes, Parkinson's disease, Medical tourism, Stroke, Technomate, Spine, Head, ENT, Epilepsy, Surgeon, COVID-19, Alzheimer's disease, Prevalence, Medtronic, R, NuVasive, Neuro, Research, Semiconductor, Video game, Dentistry, Pharmaceutical industry, Potash, Growth

The global intraoperative neuromonitoring (IONM) market size reached US$ 3.12 Billion in 2021.

Key Points: 
  • The global intraoperative neuromonitoring (IONM) market size reached US$ 3.12 Billion in 2021.
  • An intraoperative neuromonitoring (IONM) system comprises a group of procedures that can detect, monitor, and confirm nerve function and help minimize the odds of neurological problems during or after neurological surgical procedures.
  • The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures.
  • What is the structure of the global intraoperative neuromonitoring (IONM) market and who are the key players?

NUVA Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Merger of NuVasive With Globus Medical

Retrieved on: 
Thursday, February 9, 2023
Sale, Wall Street, Acquisition, NuVasive, Globus Medical, News, Wohl, Security (finance), Retail, Globus

MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive”) acted in the best interests of NuVasive shareholders in approving the merger of NuVasive with Globus Medical, Inc. (“Globus”) in an all-stock transaction pursuant to which 0.75 shares of Globus will be exchanged for each share of NuVasive.

Key Points: 
  • MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive”) acted in the best interests of NuVasive shareholders in approving the merger of NuVasive with Globus Medical, Inc. (“Globus”) in an all-stock transaction pursuant to which 0.75 shares of Globus will be exchanged for each share of NuVasive.
  • The share exchange values NuVasive at $57.72 per share based on Globus’ last close.
  • However, Globus’s stock price is down sharply today on the news, which has substantially reduced the value of the deal to NuVasive shareholders.
  • “We are investigating whether NuVasive’s Board acted in the best interests of NuVasive shareholders in approving the sale,” explained Joshua Fruchter, a partner in the firm.

Surgical Navigation Systems Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Tuesday, January 3, 2023
Organization, Intersection, Endometrial cancer, Johnson & Johnson, Surgeon, RI, 2000 Goody's Body Pain 500, Journal, Zimmer Biomet, Stryker Corporation, CT, COVID-19, Smith & Nephew, Hospital, Gynaecology, ENT, NuVasive, Bleeding, Physician, Geography, Magnetic resonance angiography, Acquisition, Siemens, Pharmaceutical industry, Medical imaging, Dentistry, Satellite navigation device, Medical device, Medtronic, Cleveland Clinic

The surgical navigation systems market is expected to grow to $10.73 billion in 2026 at a CAGR of 12.3%.

Key Points: 
  • The surgical navigation systems market is expected to grow to $10.73 billion in 2026 at a CAGR of 12.3%.
  • The main types of technologies in surgical navigation systems are electromagnetic navigation systems, optical navigation systems, hybrid navigation systems, fluoroscopy-based navigation systems, CT-based navigation systems, and others.Electromagnetic navigation system refers to the use of electromagnetic wave-assisted software to gather an image of soft tissue or cavity of the body to perform surgery.
  • The various applications include neurosurgery navigation systems, orthopedic navigation systems, ENT navigation systems, dental navigation systems, and others that are used by hospitals, physician practices, and ambulatory settings end users.
  • The surgical navigation systems market research report is one of a series of new reports that provides Surgical navigation systems market statistics, including surgical navigation systems industry global market size, regional shares, competitors with surgical navigation systems market share, detailed Surgical navigation systems market segments, market trends, and opportunities, and any further data you may need to thrive in the surgical navigation systems industry.

NuVasive to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, December 12, 2022
Software, Conference, Spine, Patient, Hospital, Surgeon, Multimedia, News, NuVasive, SAN, Elective surgery, Online shopping, Risk management

SAN DIEGO, Dec. 12, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco onThursday, January 12, 2023 at 7:30 a.m. PT.

Key Points: 
  • SAN DIEGO, Dec. 12, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco onThursday, January 12, 2023 at 7:30 a.m. PT.
  • A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com .
  • After the live webcast, a replay of the presentation will remain available on the website for 30 days.
  • NuVasive, Inc.(NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.

NuVasive Showcases Latest Innovation in Virtual Global Event

Retrieved on: 
Thursday, November 17, 2022
SAN, Elective surgery, Deformity, SPS, News, Spine, University, Surgeon, Software, Legacy Health, Standard of care, Multimedia, Patient, Sacrum, Hospital, World of McIntosh Experience Center, Prone position, NuVasive, Houston Methodist Hospital, MR, Decompression, Renewable energy, Medicine, Medical device, Northwestern Medicine, EU, Pulse, X360, Commercial software

SAN DIEGO, Nov. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, held a virtual event yesterday showcasing the Company's latest innovation across its market-leading 360 portfolios.

Key Points: 
  • SAN DIEGO, Nov. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, held a virtual event yesterday showcasing the Company's latest innovation across its market-leading 360 portfolios.
  • NuVasivedelivered a one-hour, virtual global event sharing how the Company's portfolios are transforming surgery, advancing care, and changing patient lives.
  • Highlights of the NuVasive Innovation Event by portfolio:
    C360 : Dr. Paul Holman, Houston Methodist Hospital, and Dr. Michael Wang, University of Miami Health System, discussed the future of cervical spine surgery with enabling technologies.
  • NuVasive, Inc.(NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.

NuVasive to Sponsor and Participate at the Cervical Spine Research Society 50th Annual Meeting

Retrieved on: 
Monday, November 14, 2022
SAN, Fantasy, Hospital, Technology, Elective surgery, Sport, News, Partnership, Software, NuVasive, Company, Pulse, Spine, Multimedia, Hospital for Special Surgery, Patient, Barrow Neurological Institute, Annual general meeting, Flying disc sports, NASDAQ, Surgeon, CSRS, TDR, Birth control, Medical device

SAN DIEGO, Nov. 14, 2022 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Cervical Spine Research Society (CSRS) as a diamond sponsor and will attend the CSRS 50th Annual Meeting held November 16 to 19 in San Diego.

Key Points: 
  • SAN DIEGO, Nov. 14, 2022 /PRNewswire/ --NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Cervical Spine Research Society (CSRS) as a diamond sponsor and will attend the CSRS 50th Annual Meeting held November 16 to 19 in San Diego.
  • "The recent launch of our leading posterior cervical fusion solution, Reline Cervical, and our annual meeting sponsorship of a preeminent cervical society, CSRS, underscores our shared belief in further advancing cervical technology," said Chris Barry, chief executive officer at NuVasive.
  • "We look forward to showcasing our comprehensive, procedurally integrated C360 portfolio, and its initial step toward intelligent surgery with full Pulse compatibility."
  • NuVasive, Inc.(NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.

NuVasive Announces Conference Call and Webcast of Third Quarter 2022 Results

Retrieved on: 
Tuesday, October 25, 2022
SAN, News, NuVasive, Risk, Webcast, Investor relations, NASDAQ, Patient, Hospital, Multimedia, Technology, Spine, Software, Company, Elective surgery, Surgeon, Medical device, Risk management

NuVasivewill hold a conference call onWednesday, November 9, 2022, at4:30 p.m.

Key Points: 
  • NuVasivewill hold a conference call onWednesday, November 9, 2022, at4:30 p.m.
  • ET / 1:30 p.m. PTto discuss the results of its financial performance for the third quarter ended September 30, 2022.
  • A live webcast of the conference call and supplemental financial information of our third quarter 2022 results will be available on the Investor Relations section of our website at www.nuvasive.com .
  • NuVasive, Inc.(NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.

Interbody Fusion Cage Global Market Report 2022: Worldwide Increases in Spinal Cord Injuries Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, October 21, 2022
Surgery, Health, Medical Devices, Aurora, Inorganic polymer, Adoption, Metal, Titanium, Growth, CAGR, Johnson & Johnson, Decompression, Hospital, Spine, Arthrodesis, Accident, Spinal fusion, Degenerative disc disease, Medtronic, Clifton Springs Hospital & Clinic, Spinal cord injury, NuVasive, Trapping

Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression.

Key Points: 
  • Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression.
  • The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur.
  • However, high cost associated with spinal fusion surgeries and dearth of skilled professionals are anticipated to impede the growth of interbody fusion cage market.
  • By product type, the market is segregated into lumbar cage, cervical cage, thoraco-lumbar cage, and thoracic cage.

NuVasive to Sponsor and Participate at EUROSPINE 2022

Retrieved on: 
Monday, October 17, 2022
SAN, News, Royal Orthopaedic Hospital, NuVasive, Deformity, Hospital, Efficiency, Paola Lattus, Workflow, Society, Birmingham Children's Hospital, NASDAQ, Patient, Siemens Healthineers, SPS, Trust law, Surgeon, Expert, Multimedia, Lausanne University Hospital, Partnership, Technology, Spine, Software, Company, Great Ormond Street Hospital, X360, Elective surgery, Medical imaging, Medical device, Pulse

SAN DIEGO, Oct. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with EUROSPINE as a gold sponsor and will attend EUROSPINE 2022 held October 19 to 21 in Milan.

Key Points: 
  • SAN DIEGO, Oct. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with EUROSPINE as a gold sponsor and will attend EUROSPINE 2022 held October 19 to 21 in Milan.
  • "Through our industry-leading set of procedural solutions, enabled by the technologies within Pulse, we continue to build the future of spine care to deliver more intelligent surgery."
  • NuVasivewill host a lunch workshop,Pulse: Where accuracy meets innovation,onWednesday, October 19from11:45 to 13:45 CESTinRoom Brown 2of Milano Convention Centre.Mr.
  • NuVasive, Inc.(NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.